In this issue of JAMA Dermatology, the North American Contact Dermatitis Group reports detailed data on 2 cohorts: male patients with facial dermatitis1 and patients with anogenital dermatitis.2 The authors are a dedicated group of experts who have been aggregating and reporting results of allergy patch testing for decades. The statistically significant results of both studies are interesting, but there is also tremendous value in the detailed results and in the Discussion sections. The information in these articles can help us improve our care of individual patients as well as improve health systems and population health. Readers are encouraged to thoroughly review and reflect on these articles.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Nedorost ST. Translating Allergic Contact Dermatitis Data to the Patients and Populations We Serve. JAMA Dermatol. 2020;156(1):25–26. doi:10.1001/jamadermatol.2019.3464
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: